Cargando…
Epidermal Growth Factor Receptor Plays an Anabolic Role in Bone Metabolism In Vivo
While the epidermal growth factor receptor (EGFR)–mediated signaling pathway has been shown to have vital roles in many developmental and pathologic processes, its functions in the development and homeostasis of the skeletal system has been poorly defined. To address its in vivo role, we constructed...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179301/ https://www.ncbi.nlm.nih.gov/pubmed/21542005 http://dx.doi.org/10.1002/jbmr.295 |
_version_ | 1782212502078095360 |
---|---|
author | Zhang, Xianrong Tamasi, Joseph Lu, Xin Zhu, Ji Chen, Haiyan Tian, Xiaoyan Lee, Tang-Cheng Threadgill, David W Kream, Barbara E Kang, Yibin Partridge, Nicola C Qin, Ling |
author_facet | Zhang, Xianrong Tamasi, Joseph Lu, Xin Zhu, Ji Chen, Haiyan Tian, Xiaoyan Lee, Tang-Cheng Threadgill, David W Kream, Barbara E Kang, Yibin Partridge, Nicola C Qin, Ling |
author_sort | Zhang, Xianrong |
collection | PubMed |
description | While the epidermal growth factor receptor (EGFR)–mediated signaling pathway has been shown to have vital roles in many developmental and pathologic processes, its functions in the development and homeostasis of the skeletal system has been poorly defined. To address its in vivo role, we constructed transgenic and pharmacologic mouse models and used peripheral quantitative computed tomography (pQCT), micro–computed tomography (µCT) and histomorphometry to analyze their trabecular and cortical bone phenotypes. We initially deleted the EGFR in preosteoblasts/osteoblasts using a Cre/loxP system (Col-Cre Egfr(f/f)), but no bone phenotype was observed because of incomplete deletion of the Egfr genomic locus. To further reduce the remaining osteoblastic EGFR activity, we introduced an EGFR dominant-negative allele, Wa5, and generated Col-Cre Egfr(Wa5/f) mice. At 3 and 7 months of age, both male and female mice exhibited a remarkable decrease in tibial trabecular bone mass with abnormalities in trabecular number and thickness. Histologic analyses revealed decreases in osteoblast number and mineralization activity and an increase in osteoclast number. Significant increases in trabecular pattern factor and structural model index indicate that trabecular microarchitecture was altered. The femurs of these mice were shorter and smaller with reduced cortical area and periosteal perimeter. Moreover, colony-forming unit–fibroblast (CFU-F) assay indicates that these mice had fewer bone marrow mesenchymal stem cells and committed progenitors. Similarly, administration of an EGFR inhibitor into wild-type mice caused a significant reduction in trabecular bone volume. In contrast, Egfr(Dsk5/+) mice with a constitutively active EGFR allele displayed increases in trabecular and cortical bone content. Taken together, these data demonstrate that the EGFR signaling pathway is an important bone regulator and that it primarily plays an anabolic role in bone metabolism. © 2011 American Society for Bone and Mineral Research. |
format | Online Article Text |
id | pubmed-3179301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Wiley Subscription Services, Inc., A Wiley Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-31793012012-05-01 Epidermal Growth Factor Receptor Plays an Anabolic Role in Bone Metabolism In Vivo Zhang, Xianrong Tamasi, Joseph Lu, Xin Zhu, Ji Chen, Haiyan Tian, Xiaoyan Lee, Tang-Cheng Threadgill, David W Kream, Barbara E Kang, Yibin Partridge, Nicola C Qin, Ling J Bone Miner Res Original Article While the epidermal growth factor receptor (EGFR)–mediated signaling pathway has been shown to have vital roles in many developmental and pathologic processes, its functions in the development and homeostasis of the skeletal system has been poorly defined. To address its in vivo role, we constructed transgenic and pharmacologic mouse models and used peripheral quantitative computed tomography (pQCT), micro–computed tomography (µCT) and histomorphometry to analyze their trabecular and cortical bone phenotypes. We initially deleted the EGFR in preosteoblasts/osteoblasts using a Cre/loxP system (Col-Cre Egfr(f/f)), but no bone phenotype was observed because of incomplete deletion of the Egfr genomic locus. To further reduce the remaining osteoblastic EGFR activity, we introduced an EGFR dominant-negative allele, Wa5, and generated Col-Cre Egfr(Wa5/f) mice. At 3 and 7 months of age, both male and female mice exhibited a remarkable decrease in tibial trabecular bone mass with abnormalities in trabecular number and thickness. Histologic analyses revealed decreases in osteoblast number and mineralization activity and an increase in osteoclast number. Significant increases in trabecular pattern factor and structural model index indicate that trabecular microarchitecture was altered. The femurs of these mice were shorter and smaller with reduced cortical area and periosteal perimeter. Moreover, colony-forming unit–fibroblast (CFU-F) assay indicates that these mice had fewer bone marrow mesenchymal stem cells and committed progenitors. Similarly, administration of an EGFR inhibitor into wild-type mice caused a significant reduction in trabecular bone volume. In contrast, Egfr(Dsk5/+) mice with a constitutively active EGFR allele displayed increases in trabecular and cortical bone content. Taken together, these data demonstrate that the EGFR signaling pathway is an important bone regulator and that it primarily plays an anabolic role in bone metabolism. © 2011 American Society for Bone and Mineral Research. Wiley Subscription Services, Inc., A Wiley Company 2011-05 2010-11-18 /pmc/articles/PMC3179301/ /pubmed/21542005 http://dx.doi.org/10.1002/jbmr.295 Text en Copyright © 2011 American Society for Bone and Mineral Research http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Original Article Zhang, Xianrong Tamasi, Joseph Lu, Xin Zhu, Ji Chen, Haiyan Tian, Xiaoyan Lee, Tang-Cheng Threadgill, David W Kream, Barbara E Kang, Yibin Partridge, Nicola C Qin, Ling Epidermal Growth Factor Receptor Plays an Anabolic Role in Bone Metabolism In Vivo |
title | Epidermal Growth Factor Receptor Plays an Anabolic Role in Bone Metabolism In Vivo |
title_full | Epidermal Growth Factor Receptor Plays an Anabolic Role in Bone Metabolism In Vivo |
title_fullStr | Epidermal Growth Factor Receptor Plays an Anabolic Role in Bone Metabolism In Vivo |
title_full_unstemmed | Epidermal Growth Factor Receptor Plays an Anabolic Role in Bone Metabolism In Vivo |
title_short | Epidermal Growth Factor Receptor Plays an Anabolic Role in Bone Metabolism In Vivo |
title_sort | epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179301/ https://www.ncbi.nlm.nih.gov/pubmed/21542005 http://dx.doi.org/10.1002/jbmr.295 |
work_keys_str_mv | AT zhangxianrong epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT tamasijoseph epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT luxin epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT zhuji epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT chenhaiyan epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT tianxiaoyan epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT leetangcheng epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT threadgilldavidw epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT kreambarbarae epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT kangyibin epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT partridgenicolac epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo AT qinling epidermalgrowthfactorreceptorplaysananabolicroleinbonemetabolisminvivo |